OncoZenge AB (publ) (STO:ONCOZ)
Sweden
· Delayed Price · Currency is SEK 5.36
+0.33 (6.56%)
May 30, 2025, 5:13 PM CET
OncoZenge AB Revenue
OncoZenge AB had revenue of 2.71M SEK in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 2.71M, up 271,300.00% year-over-year. In the year 2024, OncoZenge AB had annual revenue of 1,000.00, down -66.67%.
Revenue (ttm)
2.71M
Revenue Growth
+271,300.00%
P/S Ratio
23.13
Revenue / Employee
2.71M
Employees
1
Market Cap
62.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,000.00 | -2.00K | -66.67% |
| Dec 31, 2023 | 3.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |